reviewNature Reviews Drug DiscoveryMar 1, 2011Closed access

Impact of high-throughput screening in biomedical research

RMRicardo MacarrónMBMartyn BanksDBDejan BojanicDBDavid BurnsDADragan A. Cirovic

GlaxoSmithKline (United States) · Bristol-Myers Squibb (United States) · +8 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,346
total citations
FWCI
67.17
Percentile
100%
References
65
Citations per year

Authors

12

Topics & keywords

Topics
Keywords
  • Drug discovery
  • Throughput
  • High-throughput screening
  • Risk analysis (engineering)
  • Business
  • Pharmaceutical industry
  • Productivity
  • Computer science
UN Sustainable Development Goals
  • Industry, innovation and infrastructure
No related works found for this paper.